Inventor · disambiguated record
Diego Cadavid
Also filed as: CADAVID DIEGO
2 granted patents·11 pending applications·4 citations·filing 2012–2021
44Inventor score
Top patents by PatentIndex Score
13 records- 0174US9717453B2Cognitive composite parameters and uses thereof for evaluating multiple sclerosisBIOGEN MA INC·Filed 2013·Granted Aug 1, 2017·4 cites·20 claims
- 0265US2021260185A1Combination Therapies and Uses for Treatment of Demyelinating DisordersBIOGEN MA INC·Filed 2020·Application pending·0 cites
- 0364US2020276303A1Combination Therapies and Uses for Treatment of Demyelinating DisordersBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 0462US2021277111A1Lingo-1 antagonists and uses for treatment of demyelinating disordersBIOGEN MA INC·Filed 2020·Application pending·0 cites
- 0560US2020216533A1Lingo-1 antagonists and uses for treatment of demyelinating disordersBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 0659US2021403556A1Dosage Regimens of Lingo-1 Antagonists and Uses for Treatment of Demyelinating DisordersBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 0754US2019038744A1Combination Therapies and Uses for Treatment of Demyelinating DisordersBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 0854US2015238602A1Combination therapies and uses for treatment of demyelinating disordersBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 0948US10435467B2LINGO-1 antagonists and uses for treatment of demyelinating disordersBIOGEN MA INC·Filed 2016·Granted Oct 8, 2019·0 cites·25 claims
- 1044US2020031924A1Dosage Regimens of Lingo-1 Antagonists and Uses for Treatment of Demyelinating DisordersBIOGEN MA INC·Filed 2017·Application pending·0 cites
- 1137US2015220693A1Disease progression parameters and uses thereof for evaluating multiple sclerosisBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 1235US2012328567A1Biomarkers predictive of therapeutic responsiveness to ifnb and uses thereofBUSHNELL STEVEN·Filed 2012·Application pending·0 cites
- 1333US2016045570A1Biomarkers predictive of therapeutic responsiveness to ifnb and uses thereofBIOGEN MA INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Diego Cadavid files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →